Mechanistic comparison of oxatomide [Supplementary Concept] structure; and Polidocanol based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
20
Shared Targets
38%
Jaccard Similarity
33%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
oxatomide and Polidocanol share 20 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.377 means 38% of the combined target set is bound by both compounds. The IDF-weighted score of 0.329 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.
Frequently Asked Questions
What do oxatomide and Polidocanol have in common?
oxatomide and Polidocanol share 20 molecular targets with a Jaccard similarity of 38%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can oxatomide and Polidocanol be combined?
oxatomide and Polidocanol share 20 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: oxatomide or Polidocanol?
Both oxatomide and Polidocanol have substantial PubMed research. View their individual profiles for full evidence scores.